Haywood G A, Rickenbacher P R, Trindade P T, Gullestad L, Jiang J P, Schroeder J S, Vagelos R, Oyer P, Fowler M B
Division of Cardiovascular Medicine and Surgery, Stanford University School of Medicine, California 94305-5246, USA.
Heart. 1996 May;75(5):455-62. doi: 10.1136/hrt.75.5.455.
To analyse the clinical characteristics of patients who died on the Stanford heart transplant waiting list and to develop a method for risk stratifying status 2 patients (outpatients).
Data were reviewed from all patients over 18 years, excluding retransplants, who were accepted for heart transplantation over an eight year period from 1986 to 1994.
548 patients were accepted for heart transplantation; 53 died on the waiting list, and 52 survived on the waiting list for over one year. On multivariate analysis only peak oxygen consumption (peak VO2: 11.7 (SD 2.7) v 15.1 (5.2) ml/kg/min, P = 0.02) and cardiac output (3.97 (1.03) v 4.79 (1.06) litres/min, P = 0.04) were found to be independent prognostic risk factors. Peak VO2 and cardiac index (CI) were then analysed in the last 141 consecutive patients accepted for cardiac transplantation. All deaths and 88% of the deteriorations to status 1 on the waiting list occurred in patients with either a CI < 2.0 or a VO2 < 12. In those with a CI < 2.0 and a VO2 < 12, 38% died or deteriorated to status 1 in the first year on the waiting list. Patients with CI > or = 2.0 and a VO2 > or = 12 all survived throughout follow up. Using a Cox's proportional hazards model with CI and peak VO2 as covariates, tables were constructed predicting the chance of surviving for (a) 60 days and (b) 1 year on the waiting list.
These data provide a basis for risk stratification of status 2 patients on the heart transplant waiting list.
分析在斯坦福心脏移植等待名单上去世患者的临床特征,并制定一种对2级患者(门诊患者)进行风险分层的方法。
回顾了1986年至1994年八年期间所有18岁以上接受心脏移植的患者的数据,不包括再次移植患者。
548例患者被接受心脏移植;53例在等待名单上去世,52例在等待名单上存活超过一年。多因素分析显示,只有峰值耗氧量(峰值VO2:11.7(标准差2.7)对15.1(5.2)ml/kg/分钟,P = 0.02)和心输出量(3.97(1.03)对4.79(1.06)升/分钟,P = 0.04)是独立的预后风险因素。然后对最后141例连续接受心脏移植的患者的峰值VO2和心脏指数(CI)进行分析。所有死亡病例以及等待名单上88%病情恶化为1级的病例均发生在CI<2.0或VO2<12的患者中。在CI<2.0且VO2<12的患者中,38%在等待名单的第一年死亡或病情恶化为1级。CI≥2.0且VO2≥12的患者在整个随访期间均存活。使用以CI和峰值VO2作为协变量的Cox比例风险模型,构建了预测在等待名单上(a)60天和(b)1年存活机会的表格。
这些数据为心脏移植等待名单上2级患者的风险分层提供了依据。